Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis

被引:61
作者
Sarcognato, Samantha [1 ]
Sacchi, Diana [1 ]
Grillo, Federica [2 ,3 ]
Cazzagon, Nora [4 ]
Fabris, Luca [5 ]
Cadamuro, Massimiliano [5 ]
Cataldo, Ivana [1 ]
Covelli, Claudia [6 ]
Mangia, Alessandra [7 ]
Guido, Maria [1 ,8 ]
机构
[1] Azienda ULSS2 Marca Trevigiana, Dept Pathol, Treviso, Italy
[2] Univ Genoa, Anat Pathol Unit, Genoa, Italy
[3] Policlin San Martino Hosp, Genoa, Italy
[4] Univ Padua, Dept Surg Oncol & Gastroenterol DISCOG, Padua, Italy
[5] Univ Padua, Dept Mol Med DMM, Padua, Italy
[6] Fdn IRCCS Casa Sollievo della Sofferenza, Pathol Unit, San Giovanni Rotondo, Italy
[7] Fdn IRCCS Casa Sollievo della Sofferenza, Liver Unit, San Giovanni Rotondo, Italy
[8] Univ Padua, Dept Med DIMED, Padua, Italy
关键词
immune-mediated cholangitis; autoimmune cholangitis; PBC; PSC; overlap variants; NONSUPPURATIVE DESTRUCTIVE CHOLANGITIS; REGULATORY T-CELLS; OVERLAP SYNDROME; NATURAL-HISTORY; HISTOLOGIC FEATURES; CLINICAL-FEATURES; GRADING SYSTEM; LIVER-BIOPSY; PLASMA-CELLS; HERING LOSS;
D O I
10.32074/1591-951X-245
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Autoimmune cholestatic liver diseases are rare hepato-biliary disorders characterized by a progressive, inflammatory destruction of bile ducts. Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are the main autoimmune cholestatic liver diseases. Both may evolve into secondary biliary cirrhosis and its complications. Therapeutic options are limited and liver transplantation remains the only definitive treatment for PBC and PSC. Most PBC and PSC patients have a typical presentation, which does not require liver biopsy. However, in routine clinical practice, important variants or specific subgroups that benefit from liver biopsy for proper management may be observed. Herein, we provide a general overview of clinical and pathological characteristic of PBC and PSC, highlighting the most important features for routine diagnostic practice.
引用
收藏
页码:170 / 184
页数:15
相关论文
共 81 条
[1]   Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline [J].
Aabakken, Lars ;
Karlsen, Tomh. ;
Albert, Joerg ;
Arvanitakis, Marianna ;
Chazouilleres, Olivier ;
Dumonceau, Jean-Marc ;
Farkkila, Martti ;
Fickert, Peter ;
Hirschfield, Gideon M. ;
Laghi, Andrea ;
Marzioni, Marco ;
Fernandez, Michael ;
Pereira, Stephen P. ;
Pohl, Juergen ;
Poley, Jan-Werner ;
Ponsioen, Cyriel Y. ;
Schramm, Christoph ;
Swahn, Fredrik ;
Tringali, Andrea ;
Hassan, Cesare .
ENDOSCOPY, 2017, 49 (06) :588-608
[2]   The utility of IgG, IgM, and CD138 immunohistochemistry in the evaluation of autoimmune liver diseases [J].
Abe, Kazumichi ;
Takahashi, Atsushi ;
Nozawa, Yoshihiro ;
Imaizumi, Hiromichi ;
Hayashi, Manabu ;
Okai, Ken ;
Kanno, Yukiko ;
Watanabe, Hiroshi ;
Ohira, Hiromasa .
MEDICAL MOLECULAR MORPHOLOGY, 2014, 47 (03) :162-168
[3]   Primary biliary cholangitis management: controversies, perspectives and daily practice implications from an expert panel [J].
Alvaro, Domenico ;
Carpino, Guido ;
Craxi, Antonio ;
Floreani, Annarosa ;
Moschetta, Antonio ;
Invernizzi, Pietro .
LIVER INTERNATIONAL, 2020, 40 (11) :2590-2601
[4]   Serum autoantibodies in patients with primary sclerosing cholangitis [J].
Angulo, P ;
Peter, JB ;
Gershwin, ME ;
DeSotel, CK ;
Shoenfeld, Y ;
Ahmed, AEE ;
Lindor, KD .
JOURNAL OF HEPATOLOGY, 2000, 32 (02) :182-187
[5]   Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria [J].
Balitzer, Dana ;
Shafizadeh, Nafis ;
Peters, Marion G. ;
Ferrell, Linda D. ;
Alshak, Najeeb ;
Kakar, Sanjay .
MODERN PATHOLOGY, 2017, 30 (05) :773-783
[6]   Cholangiocyte pathobiology [J].
Banales, Jesus M. ;
Huebert, Robert C. ;
Karlsen, Tom ;
Strazzabosco, Mario ;
LaRusso, Nicholas F. ;
Gores, Gregory J. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (05) :269-281
[7]   The challenges of primary biliary cholangitis: What is new and what needs to be done [J].
Benedetta, Terziroli Beretta-Piccoli ;
Mieli-Vergani, Giorgina ;
Vergani, Diego ;
Vierling, John M. ;
Adams, David ;
Alpini, Gianfranco ;
Banales, Jesus M. ;
Beuers, Ulrich ;
Bjornsson, Einar ;
Bowlus, Christopher ;
Carbone, Marco ;
Chazouilleres, Olivier ;
Dalekos, George ;
De Gottardi, Andrea ;
Harada, Kenichi ;
Hirschfield, Gideon ;
Invernizzi, Pietro ;
Jones, David ;
Krawitt, Edward ;
Lanzavecchia, Antonio ;
Lian, Zhe-Xiong ;
Ma, Xiong ;
Manns, Michael ;
Mavilio, Domenico ;
Quigley, Eamon M. M. ;
Sallusto, Federica ;
Shimoda, Shinji ;
Strazzabosco, Mario ;
Swain, Mark ;
Tanaka, Atsushi ;
Trauner, Michael ;
Tsuneyama, Koichi ;
Zigmond, Ehud ;
Gershwin, M. Eric .
JOURNAL OF AUTOIMMUNITY, 2019, 105
[8]   Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue [J].
Boberg, Kirsten Muri ;
Chapman, Roger W. ;
Hirschfield, Gideon M. ;
Lohse, Ansgar W. ;
Manns, Michael P. ;
Schrumpf, Erik .
JOURNAL OF HEPATOLOGY, 2011, 54 (02) :374-385
[9]   The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis [J].
Carbone, Marco ;
Sharp, Stephen J. ;
Flack, Steve ;
Paximadas, Dimitrios ;
Spiess, Kelly ;
Adgey, Carolyn ;
Griffiths, Laura ;
Lim, Reyna ;
Trembling, Paul ;
Williamson, Kate ;
Wareham, Nick J. ;
Aldersley, Mark ;
Bathgate, Andrew ;
Burroughs, Andrew K. ;
Heneghan, Michael A. ;
Neuberger, James M. ;
Thorburn, Douglas ;
Hirschfield, Gideon M. ;
Cordell, Heather J. ;
Alexander, Graeme J. ;
Jones, David E. J. ;
Sandford, Richard N. ;
Mells, George F. .
HEPATOLOGY, 2016, 63 (03) :930-950
[10]   Primary biliary cirrhosis [J].
Carey, Elizabeth J. ;
Ali, Ahmad H. ;
Lindor, Keith D. .
LANCET, 2015, 386 (10003) :1565-1575